Changing the Biosimilars Value Equation: Novel Considerations for Formulary Management.

This document discusses the challenges and opportunities associated with the use of biosimilars in healthcare. Biosimilars are lower-cost alternatives to biologic drugs, which are expensive and account for a significant portion of total US drug costs. The adoption of biosimilars has been hindered by factors such as lack of interchangeability with reference products, prescriber and patient misperceptions, and insurance coverage variability. The document presents a case study of a health system that developed a strategy for efficient utilization of biosimilars, resulting in decreased drug costs and enhanced reimbursement. The study highlights the importance of interdisciplinary collaboration and robust assessment of the pharmacy revenue cycle in addressing formulary management of biosimilars. [Extracted from the article]